Home Cart Sign in  
Chemical Structure| 1135242-13-5 Chemical Structure| 1135242-13-5

Structure of VU0357017 HCl
CAS No.: 1135242-13-5

Chemical Structure| 1135242-13-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

VU 0357017 HCl is a positive allosteric modulator of muscarinic M1 receptors with EC50 value of 198 nM.

Synonyms: CID-25010775; VU0357017 (hydrochloride); VU0357017, VU-0357017, VU 0357017, CID 25010775, CID25010775, CID-25010775

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of VU0357017 HCl

CAS No. :1135242-13-5
Formula : C18H28ClN3O3
M.W : 369.89
SMILES Code : O=C(N1CCC(NCCNC(C2=CC=CC=C2C)=O)CC1)OCC.[H]Cl
Synonyms :
CID-25010775; VU0357017 (hydrochloride); VU0357017, VU-0357017, VU 0357017, CID 25010775, CID25010775, CID-25010775
MDL No. :MFCD17215959
InChI Key :XKJQVUIXSBOCPP-UHFFFAOYSA-N
Pubchem ID :25010775

Safety of VU0357017 HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
CHO cells 37.0 µM 5 minutes Induced ERK1/2 phosphorylation, with a maximal response of 37.9% of CCh max J Neurosci. 2012 Jun 20;32(25):8532-44
CHO cells 1.60 µM 60 seconds Induced calcium mobilization, with a maximal response of 41.7% of CCh max J Neurosci. 2012 Jun 20;32(25):8532-44

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Morris water maze test Intraperitoneal injection 0.1, 0.3, 0.56, 1, 3 mg/kg Once daily for 5 days Enhanced hippocampal-dependent cognitive function, but did not significantly improve spatial memory J Neurosci. 2012 Jun 20;32(25):8532-44
Mice MK-801-induced cognitive impairment model Intraperitoneal injection 0.15-5 mg/kg Once daily for 7 consecutive days Reversed MK-801-induced cognitive deficits Int J Mol Sci. 2021 Aug 10;22(16):8612
CD-1 mice MK-801-induced spatial memory impairment model Intraperitoneal injection 0.25, 0.5, and 1 mg/kg Daily administration for 5 days of training VU0357017 at 0.25 mg/kg prevented MK-801-induced spatial learning impairments, but was ineffective at 0.5 and 1 mg/kg. Biomolecules. 2023 Jun 30;13(7):1064
Rats Contextual fear conditioning model Intraperitoneal injection 10 mg/kg Single dose Evaluate the effect of VU0357017 in reversing scopolamine-induced cognitive deficits ACS Chem Neurosci. 2010;1(2):104-121
Mice M1 and M4 receptor knockout mice Subcutaneous injection 1–18 mg/kg 15 min before cocaine VU0357017 produced rightward shifts in the cocaine dose-effect curve in wild-type and M4?/? mice, but not in M1?/? mice. Response rates were unaffected by VU0357017. Psychopharmacology (Berl). 2012 Apr;220(4):673-85
Male C57BL/6J mice Cocaine self-administration model Subcutaneous injection 5.6 mg/kg Immediately after each extinction session To test the effect of VU0357017 alone on extinction of cocaine-seeking behavior, results showed that VU0357017 alone did not significantly modify rates of extinction Psychopharmacology (Berl). 2018 Mar;235(3):815-827

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.70mL

0.54mL

0.27mL

13.52mL

2.70mL

1.35mL

27.04mL

5.41mL

2.70mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories